Company: BDRX
Filing Date: 2025-05-08
Form Type: POS AM
Source: 0001214659-25-007201
Chunk: 112

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-05-08
Form: POS AM
Chunk 112
---
 beneficial ownership limitation. The amounts and percentages in the       
 table do not give effect to the 9.99% beneficial ownership limitation, if applicable. The principal business address of District 2 Capital 
 Fund LP is 14 Wall Street, 2nd Floor, Huntington, NY 11743.                                                                                |

| (6) | The selling                                                                                                                                   
 shareholder holds (i) warrants issued by us in prior transactions which entitle the selling shareholder                                       
 to purchase an aggregate of 103,790,000 Ordinary Shares (in the form of Depositary Shares), and (ii) Series                                   
 J Warrants issued by us which entitle the selling shareholder to purchase an aggregate of 276,590,000 Ordinary Shares (in the form of         
 Depositary Shares) and Series K Warrants issued by us which entitle the selling shareholder to purchase an aggregate of 276,590,000 Ordinary  
 Shares (in the form of Depositary Shares) and which we are registering hereby. The warrants are subject to a beneficial ownership limitation  
 of 4.99% or 9.99%, as applicable, which does not permit the selling shareholder to exercise that portion of the warrants that would result    
 in the selling shareholder and its affiliates owning, after exercise, a number of our Ordinary Shares in excess of the beneficial ownership   
 limitation. The amounts and percentages in the table do not give effect to the 4.99% or 9.99% beneficial ownership limitation, if applicable. 
 Richard Abbe is the managing member of Iroquois Capital Investment Group LLC. Mr. Abbe has voting control and investment discretion over      
 securities held by Iroquois Capital Investment Group LLC. As such, Mr. Abbe may be deemed to be the beneficial owner (as determined under     
 Section 13(d) of the Securities Exchange Act of 1934, as amended) of the securities held by Iroquois Capital Investment Group LLC. The        
 principal business address of Iroquois Capital Investment Group LLC is 2 Overhill Road, Suite 400, Scarsdale, NY 10583.                       |

| (7) | The selling                                                                                                                                   
 shareholder holds (i) warrants issued by us in prior transactions which entitle the selling shareholder                                       
 to purchase an aggregate of 85,910,000 Ordinary Shares (in the form of Depositary Shares), and (ii) Series                                    
 J Warrants issued by us which entitle the selling shareholder to purchase an aggregate of 148,930,000